Correlation Engine 2.0
Clear Search sequence regions


  • acid (9)
  • ascorbic acid (13)
  • fourier transform (2)
  • hydroxyl (2)
  • near (1)
  • powder (1)
  • skeleton (1)
  • solvent (1)
  • TRT 1 (10)
  • Sizes of these terms reflect their relevance to your search.

    The purpose of this study was to prepare solid dispersions of triamterene (TRT) with ascorbic acid (AA) or ascorbic acid 2 glucoside (AA2G) and to evaluate their physical properties. Solid dispersions were prepared by dissolving each sample in an organic solvent and evaporation (EVP). Powder X-ray diffraction (PXRD) revealed a halo pattern for EVP1 (AA/TRT = 1/1) and EVP2 (AA2G/TRT = 1/1). In differential scanning calorimetry (DSC), endothermic peaks due to the melting of TRT and AA disappeared for EVP1 (AA/TRT = 1/1), and the melting peaks of TRT and AA2G disappeared for EVP2 (AA2G/TRT = 1/1). Fourier transform infrared (FT-IR) spectroscopy revealed broadened peaks for EVP1 (AA/TRT = 1/1) and EVP2 (AA2G/TRT = 1/1) due to the hydroxyl groups (-OH) of AA and the amino groups (-NH2) of TRT and also revealed a peak shift due to the pteridine skeleton (C = N) of TRT. In near-infrared absorption (NIR) spectroscopy, peaks due to the hydroxyl groups (-OH) of AA and AA2G were found for EVP1 (AA/TRT = 1/1) and EVP2 (AA2G/TRT = 1/1), respectively. A peak due to the amino groups (-NH2) was evident. This suggested the formation of an evaporation, in which TRT interacted with AA or AA2G. In the dissolution test, the dissolved fraction of TRT alone after 3 min was 30%, whereas the fractions were enhanced to approximately 90% for EVP1 (AA/TRT = 1/1) and EVP2 (AA2G/TRT= 1/1). Results confirmed that dissolution properties were improved as a result of complex formation. The above findings indicated improvement the dissolution properties of TRT.

    Citation

    Hirotaka Onoda, Yutaka Inoue, Toshinari Ezawa, Isamu Murata, Takron Chantadee, Sontaya Limmatvapirat, Toshio Oguchi, Ikuo Kanamoto. Preparation and characterization of triamterene complex with ascorbic acid derivatives. Drug development and industrial pharmacy. 2020 Dec;46(12):2032-2040

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33104388

    View Full Text